Skip to content

An Analysis of Dermabond vs. Non-Absorbable Sutures in Skin Closure for Brow Ptosis Procedures

Scar Analysis in Direct Excision Brow Lift: Comparing Octyl-2- Cyanoacrylate (Dermabond) Versus Non-absorbable Sutures

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05981443
Enrollment
8
Registered
2023-08-08
Start date
2023-08-15
Completion date
2024-04-17
Last updated
2025-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brow Ptosis, Surgical Wound

Brief summary

The goal of this clinical trial is to compare Dermabond with non-absorbable sutures in skin closure after brow ptosis surgery. The main questions it aims to answer are: * if Dermabond provides equivalent wound healing compared to conventional non-absorbable skin suture techniques * if Dermabond provides equivalent scar appearance compared to conventional non-absorbable suture techniques * if Dermabond results in equivalent complication rates compared to conventional non-absorbable suture techniques Participants will have be randomly selected to have either Dermabond or non-absorbable suture closure methods. Scar analysis and both participant and provider surveys will be performed to assess the differences between groups, if any.

Interventions

DEVICEDermabond

Use of Dermabond to close surgical incisions instead of non-absorbable sutures

Use of conventional non-absorbable sutures to close surgical incisions

Sponsors

Cody Blanchard
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing bilateral direct excision brow lift for brow ptosis at the University of Kentucky Medical Center. * Patients \> 18 years of age. * Patients must be able to follow up at the specified intervals. * Patients who are able to give their own informed consent. * Health Status: Variable health status reflective of general population of Kentucky. Patients will be healthy enough to be seen in an office setting. * All patients will need to be proficient in the English language to understand the scale used for scar assessment

Exclusion criteria

* Patients \<18 years of age or \>100 * Allergy to Dermabond * Adults with impaired consent capacity * Incarcerated individuals

Design outcomes

Primary

MeasureTime frameDescription
Scar Appearance10 daysPatient and Observer Scar Assessment Scale filled out by both patient and provider at both postoperative visits of both Dermabond and non-absorbable sutures. This survey is scaled from 0-10, with 0 being normal skin and 10 being very different skin. Lower scores are desired on this survey.
Number of Participants With Complications6 weeksComplications of both Dermabond and non-absorbable sutures to include dehiscence and infection

Countries

United States

Participant flow

Participants by arm

ArmCount
Active Comparator: Dermabond
The surgical wound over one eyebrow will be closed with Dermabond. Dermabond: Use of Dermabond to close surgical incisions instead of non-absorbable sutures
3
Active Comparator: Non-Absorbable Sutures
The surgical wound over one eyebrow will be closed with non-absorbable sutures. Non-Absorbable Sutures: Use of conventional non-absorbable sutures to close surgical incisions
3
Total6

Baseline characteristics

CharacteristicActive Comparator: DermabondTotalActive Comparator: Non-Absorbable Sutures
Age, Continuous69 years
STANDARD_DEVIATION 2
73 years
STANDARD_DEVIATION 5.4
77 years
STANDARD_DEVIATION 3.7
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
3 Participants6 Participants3 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
3 Participants6 Participants3 Participants
Region of Enrollment
United States
3 participants6 participants3 participants
Sex: Female, Male
Female
1 Participants3 Participants2 Participants
Sex: Female, Male
Male
2 Participants3 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 30 / 3
other
Total, other adverse events
0 / 30 / 3
serious
Total, serious adverse events
0 / 30 / 3

Outcome results

Primary

Number of Participants With Complications

Complications of both Dermabond and non-absorbable sutures to include dehiscence and infection

Time frame: 6 weeks

ArmMeasureValue (NUMBER)
Active Comparator: DermabondNumber of Participants With Complications0 participants
Active Comparator: Non-Absorbable SuturesNumber of Participants With Complications0 participants
Primary

Scar Appearance

Patient and Observer Scar Assessment Scale filled out by both patient and provider at both postoperative visits of both Dermabond and non-absorbable sutures. This survey is scaled from 0-10, with 0 being normal skin and 10 being very different skin. Lower scores are desired on this survey.

Time frame: 10 days

ArmMeasureValue (MEAN)
Active Comparator: DermabondScar Appearance7 score on a scale
Active Comparator: Non-Absorbable SuturesScar Appearance2.33 score on a scale
Primary

Scar Appearance

Patient and Observer Scar Assessment Scale filled out by both patient and provider at both postoperative visits of both Dermabond and non-absorbable sutures. This survey is scaled from 0-10, with 0 being normal skin and 10 being very different skin. Lower scores are desired on this survey.

Time frame: 6 weeks

ArmMeasureValue (MEAN)
Active Comparator: DermabondScar Appearance2 score on a scale
Active Comparator: Non-Absorbable SuturesScar Appearance4 score on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026